Elanco Animal Health Incorporated, commonly known as Elanco, is a leading global animal health company headquartered in the United States. Founded in 1954, Elanco has established itself as a key player in the animal health industry, focusing on innovative solutions for both livestock and companion animals. With a strong presence in North America, Europe, and Asia, the company offers a diverse range of products and services, including pharmaceuticals, vaccines, and nutritional products. Elanco's commitment to improving animal health and welfare is evident in its unique offerings, which are designed to enhance productivity and sustainability in animal agriculture. The company has achieved notable milestones, including the launch of several groundbreaking products that address critical health challenges in animals. As a trusted partner in the animal health sector, Elanco continues to strengthen its market position through research and development, ensuring a healthier future for animals and the people who care for them.
How does Elanco's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Elanco's score of 62 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Elanco reported total greenhouse gas emissions of approximately 974.9 million kg CO2e, comprising 175,807,000 kg CO2e from Scope 1, 302,607,000 kg CO2e from Scope 2, and 496,505,000 kg CO2e from Scope 3 emissions. This represents a slight decrease from 2023, where total emissions were approximately 1,085.6 million kg CO2e, with Scope 1 emissions at 145,021,000 kg CO2e, Scope 2 at 285,188,000 kg CO2e, and Scope 3 at 655,353,000 kg CO2e. Elanco has set ambitious climate commitments, aiming for net zero Scope 1 and 2 emissions by 2030 for its Hook office. Additionally, the company is committed to helping its customers avoid approximately 21 million metric tons of GHG emissions by 2030, using 2020 as a baseline. This commitment is part of a broader strategy to purchase renewable electricity equal to 100% of its electricity consumption by 2030. Elanco is also aligned with the Science Based Targets initiative (SBTi), having committed to long-term net zero targets across all scopes by 2050. The company's U.K. and Ireland affiliate has set a goal to eliminate internal combustion engine vehicles from its fleet by 2030, further demonstrating its commitment to reducing carbon emissions. Overall, Elanco's emissions data and climate commitments reflect a proactive approach to sustainability, with clear targets and initiatives aimed at reducing its environmental impact.
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 274,550,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 418,271,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Elanco has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


Common questions about Elanco's sustainability data and climate commitments
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.